pharma · Osteoarthritis · Osteoporosis
Nordic Bioscience
Nordic Bioscience A/S
Nordic Bioscience A/S is a pharma organization headquartered in Herlev, DK. Primary therapeutic focus areas include Osteoarthritis, Osteoporosis, Ovarian cancer, Advanced prostate cancer, Atopic dermatitis. NovaPharmaNew
Herlev, DK HQ
1991 Founded
228 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Herlev, DK
- Founded
- 1991
- Employees
- 228
- Programs
- 5
- Drugs
- 10
- Patents
- 0
SMC021 Oral Calcitonin
Phase 3 · small molecule · Osteoarthritis
SMC021 Oral Calcitonin for Osteoarthritis is a Phase 3 program (small_molecule) at Nordic Bioscience A/S with 1 ClinicalTrials.gov record(s).
Internal code CSMC021C2301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nordic Bioscience A/S
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Osteoarthritis
- Status
- completed
- Trials
- 1